Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067782
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2003-08-27
Brief Title:
A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb